Outcome of orthotopic liver transplantation in autoimmune hepatitis according to subtypes

Transplant International

Volumn 15, Issue 1, 2002, Pages 34-38

  Cattan, Pierre ^a,b   Berney, Thierry ^c   Conti, Filomena ^b   Calmus, Yvon ^b   Homberg, J C ^d   Houssin, Didier ^b   Soubrane, Olivier ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b Hôpital Cochin ^*  (France)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

Autoimmune hepatitis; Liver transplantation; Subtypes

Indexed keywords

CYCLOSPORIN; OKT 3; STEROID;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; DISEASE CLASSIFICATION; FEMALE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; REOPERATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036940248     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2002.tb00095.x     Document Type: Article

References (27)

1. Czaja A, Carpenter HA (1996) Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci 41:305-314
2. Czaja AJ, Manns MP (1995) The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol 90:1206-1211
3. Czaja AJ, Rakela J, Ludwig J (1988) Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis. Gastroenterology 95:448-453
4. Davis GL, Czaja AJ, Ludwig J (1984) Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis. Gastroenterology 87:1222-1227
5. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ (1994) Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19:1513-1520
6. Donaldson PT, Doherty DG, Hayllar KM, MacFarlane IG, Johnson PJ, Williams R (1990) Susceptibility to auto-immune chronic active hepatitis: HLA DR4 and A1BSDR3 are independent risk factors. Hepatology 13:701-706
7. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections. Am J Infect Control 66:128-140
8. Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, Darnis F, Lévy VG, Grippon P, Opollon P, Bernuau J, Benhamou JP, Alagille D (1987) Chronic active hepatitis associated with anti-liver/kidney microsome antibody type I: a second type of "autoimmune" hepatitis. Hepatology 7:1333-1339
9. Houssin D, Soubrane O, Boillot O, Dousset B, Ozier Y, Devictor D, Berbard O, Chapuis Y (1992) Orthotopic liver transplantation with a reduced-size graft: an ideal compromise in pediatrics? Surgery 111:532-542
10. Houssin D, Boillot O, Soubrane O, Couinaud C, Pitre J, Ozier Y, Devictor D, Bernard O, Chapuis Y (1993) Controlled liver splitting for transplantation in two recipients: technique, results and perspectives. Br J Surg 80:75-80
11. International Working Party (1995) Terminology of chronic hepatitis. Am J Gastroenterol 90:181-189
12. Johnson PJ, McFarlane IG (1993) Meeting report. International Autoimmune Hepatitis Group. Hepatology 18:998-1005
13. Johnson PJ, McFarlane IG, Eddelson ALWF (1991) The natural course and heterogeneity of autoimmune type chronic active hepatitis. Semin Liver Dis 11:187-196
14. Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Buschenfelde KH (1987) Characterization of a new subgroup of autoimmune chronic hepatitis by autoantibodies against a soluble liver antigen. Lancet 1:292-294
15. Merigan TC, Renlund DG, Keay S, Bristow MR, Starnes V, O'Connell JB, Resta S, Dunn D, Gamberg P, Ratkovec RM (1992) A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med 326:1182-1186
16. Milkiewicz P, Ahmed M, Hathaway M, Elias E (1999) Factors associated with progression of the disease before transplantation in patients with autoimmune hepatitis. Liver 19:50-54
17. Murray-Lyon IM, Stern RB, Williams R (1973) Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet I:735-737
18. Nikias GA, Batts KP, Czaja AJ (1994) The nature and prognostic implications of "acute" type I autoimmune hepatitis. Gastroenterology 106:A950
19. Porta G, Da Costa Gayotto LC, Alvarez F (1990) Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure. J Pediatr Gastroenterol Nutr 11:138-140
20. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646-649
21. Ratziu V, Samuel D, Sebagh M, Farges O, Saliba F, Icai P, Farahmand H, Gigou M, Feray C, Reynes M, Bismuth H (1999) Longterm follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. J Hepatol 30:131-141
22. Roberts SK, Therneau TM, Czaja AJ (1996) Prognosis of histological cirrhosis in type I autoimmune hepatitis. Gastroenterology 110:848-857
23. Roitt IM, Doniach D (1972) Immunofluorescent tests for the detection of antibodies. In: WHO booklet of immunological techniques. WHO, Geneva, pp 1-12
24. Sanchez-Urdazpal L, Czaja AJ, van Hoek B, Krom RA, Wiesner RH (1992) Prognosis features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology 15:215-221
25. Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL (1987) Liver rejection: an analysis of the use of biopsy in determining outcome of rejection. Am J Surg 11:1-10
26. Starzl TE, Iwatsuki S, Esquivel CO, Todo S, Kam I, Lynch S, Gordon RD, Shaw BW Jr (1985) Refinements in the surgical technique of liver transplantation. Semin Liver Dis 5:349-356
27. Wright HL, Bou-Abboud CF, Hassanein T, Block GD, Demetris AJ, Starzl TE, Van Thiel DH (1992) Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease. Transplantation 53:136-139